Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rumneek Bedi

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Retinal Cases & Brief Reports|November 6, 2014
Retinal infiltrates secondary to metastatic squamous cell carcinoma masquerading as infectious retinitisRishi P Singh, Nathan C Steinle, Rumneek Bedi, et al.
The British Journal of Ophthalmology|May 20, 2014
A single-arm, investigator-initiated study of the efficacy, safety and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration, previously treated with ranibizumab or bevacizumab: 6-month interim analysisRishi P Singh, Sunil Srivastava, Justis P Ehlers, et al.
Indian Journal of Ophthalmology|December 21, 2019
Subretinal hyperreflective material in central serous chorioretinopathyNiroj K Sahoo, Vishal Govindhari, Rumneek Bedi, et al.
Ophthalmology. Retina|May 4, 2019
A 24-Month Evaluation of Aflibercept for Wet Age-Related Macular Degeneration in Patients Previously Receiving Ranibizumab or BevacizumabFabiana Q Silva, Sunil Srivastava, Justis P Ehlers, et al.
JAMA Ophthalmology|April 17, 2015
The Practice Impact of Electronic Health Record System Implementation Within a Large Multispecialty Ophthalmic PracticeRishi P Singh, Rumneek Bedi, Ang Li, et al.
International Journal of Ophthalmology|May 5, 2015
Oral eplerenone for the management of chronic central serous chorioretinopathyRishi P Singh, Jonathan E Sears, Rumneek Bedi, et al.
Clinical Ophthalmology (Auckland, N.Z.)|October 8, 2015
A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysisRishi P Singh, Sunil K Srivastava, Justis P Ehlers, et al.
The British Journal of Ophthalmology|December 21, 2013
Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndromeRishi P Singh, Ang Li, Rumneek Bedi, et al.
The British Journal of Ophthalmology|March 5, 2017
A retrospective study of the influence of the vitreomacular interface on macular oedema secondary to retinal vein occlusionRishi P Singh, Karishma A Habbu, Rumneek Bedi, et al.
Retina (Philadelphia, Pa.)|June 26, 2015
OUTCOMES OF TREATMENT OF CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH CENTRAL SEROUS CHORIORETINOPATHY WITH INTRAVITREAL ANTIANGIOGENIC AGENTSJay Chhablani, Igor Kozak, Francesco Pichi, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Retinal Cases & Brief Reports|November 6, 2014
Retinal infiltrates secondary to metastatic squamous cell carcinoma masquerading as infectious retinitisRishi P Singh, Nathan C Steinle, Rumneek Bedi, et al.
The British Journal of Ophthalmology|May 20, 2014
A single-arm, investigator-initiated study of the efficacy, safety and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration, previously treated with ranibizumab or bevacizumab: 6-month interim analysisRishi P Singh, Sunil Srivastava, Justis P Ehlers, et al.
Indian Journal of Ophthalmology|December 21, 2019
Subretinal hyperreflective material in central serous chorioretinopathyNiroj K Sahoo, Vishal Govindhari, Rumneek Bedi, et al.
Ophthalmology. Retina|May 4, 2019
A 24-Month Evaluation of Aflibercept for Wet Age-Related Macular Degeneration in Patients Previously Receiving Ranibizumab or BevacizumabFabiana Q Silva, Sunil Srivastava, Justis P Ehlers, et al.
JAMA Ophthalmology|April 17, 2015
The Practice Impact of Electronic Health Record System Implementation Within a Large Multispecialty Ophthalmic PracticeRishi P Singh, Rumneek Bedi, Ang Li, et al.
International Journal of Ophthalmology|May 5, 2015
Oral eplerenone for the management of chronic central serous chorioretinopathyRishi P Singh, Jonathan E Sears, Rumneek Bedi, et al.
Clinical Ophthalmology (Auckland, N.Z.)|October 8, 2015
A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysisRishi P Singh, Sunil K Srivastava, Justis P Ehlers, et al.
The British Journal of Ophthalmology|December 21, 2013
Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndromeRishi P Singh, Ang Li, Rumneek Bedi, et al.
The British Journal of Ophthalmology|March 5, 2017
A retrospective study of the influence of the vitreomacular interface on macular oedema secondary to retinal vein occlusionRishi P Singh, Karishma A Habbu, Rumneek Bedi, et al.
Retina (Philadelphia, Pa.)|June 26, 2015
OUTCOMES OF TREATMENT OF CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH CENTRAL SEROUS CHORIORETINOPATHY WITH INTRAVITREAL ANTIANGIOGENIC AGENTSJay Chhablani, Igor Kozak, Francesco Pichi, et al.
Pageof 1